Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Dickgreber

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2011
Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trialWolfgang Schuette, Sylke Nagel, Ludwig Fischer von Weikersthal, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 27, 2016
GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancerMichael Flentje, Rudolf M Huber, Walburga Engel-Riedel, et al.
Current Medical Research and Opinion|May 25, 2019
Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancerRamaswamy Govindan, Suresh Senan, Nicolas Dickgreber, et al.
Investigational New Drugs|June 20, 2014
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancerEmiliano Calvo, Victor J Chen, Mark Marshall, et al.
Respiration; International Review of Thoracic Diseases|March 3, 2026
Treatment outcomes of endoscopic lung volume reduction with valves in advanced lung emphysema patients are largely independent of body mass index: Data from the German Lung Emphyema RegistryJacopo Saccomanno, Thomas Sgarbossa, Konrad Neumann, et al.
Infection|February 13, 2026
Peri-interventional antibiotic prophylaxis in endoscopic valve implantation for lung volume reduction in COPD patients: results from a German multicenter observational cohortEva Pappe, Hadis Darvishi, Thomas Sgarbossa, et al.
Journal of Occupational Medicine and Toxicology (London, England)|April 13, 2010
Mobile Air Quality Studies (MAQS)-an international projectDavid A Groneberg, Cristian Scutaru, Mathias Lauks, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2011
Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trialWolfgang Schuette, Sylke Nagel, Ludwig Fischer von Weikersthal, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 27, 2016
GILT--A randomised phase III study of oral vinorelbine and cisplatin with concomitant radiotherapy followed by either consolidation therapy with oral vinorelbine and cisplatin or best supportive care alone in stage III non-small cell lung cancerMichael Flentje, Rudolf M Huber, Walburga Engel-Riedel, et al.
Current Medical Research and Opinion|May 25, 2019
Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancerRamaswamy Govindan, Suresh Senan, Nicolas Dickgreber, et al.
Investigational New Drugs|June 20, 2014
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancerEmiliano Calvo, Victor J Chen, Mark Marshall, et al.
Respiration; International Review of Thoracic Diseases|March 3, 2026
Treatment outcomes of endoscopic lung volume reduction with valves in advanced lung emphysema patients are largely independent of body mass index: Data from the German Lung Emphyema RegistryJacopo Saccomanno, Thomas Sgarbossa, Konrad Neumann, et al.
Infection|February 13, 2026
Peri-interventional antibiotic prophylaxis in endoscopic valve implantation for lung volume reduction in COPD patients: results from a German multicenter observational cohortEva Pappe, Hadis Darvishi, Thomas Sgarbossa, et al.
Journal of Occupational Medicine and Toxicology (London, England)|April 13, 2010
Mobile Air Quality Studies (MAQS)-an international projectDavid A Groneberg, Cristian Scutaru, Mathias Lauks, et al.
Pageof 2